$石四藥集團.HK公布，集團已取得國家藥品監督管理局有關鹽酸烏拉地爾注射液的藥品生產註冊批件，屬於化學藥品第 4 類，視同通過一致性評價。鹽酸烏拉地爾注射液主要用於治療高血壓危象，如血壓急劇升高，重度和極重度高血壓及難治性高血壓，以及用於控制圍手術期高血壓。
Traded Value
OrdersThe copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Like